Elysian Capital

About Elysian Capital

Elysian Capital is a UK and Ireland lower-mid-market private equity firm with approximately £700 million of cumulative assets as of December 2024 (Fund III closed October 2020 at £325 million hard cap), headquartered in London. The firm was founded in 2007 by Ken Terry and Mark Puttick (Mark Puttick now CEO) and operates as a partner-owned LLP with unusually high personal capital commitments by partners. The 'More than a private equity firm. We're true partners' positioning reflects the partner-aligned model with significant personal capital commitments above industry norms.

Investment thesis

Elysian Capital deploys capital through three flagship funds (Elysian Capital I, II, III), targeting UK and Ireland lower-mid-market private equity acquiring majority stakes in growth businesses valued £20-100 million. The strategy emphasises partnership with entrepreneurial management teams plus operational value creation. Sector focus spans healthcare, business services, industrials, energy and utilities, business goods and marketing services. Geographic deployment is UK and Ireland core with US expansion support for portfolio companies.

Recent activity

Recent realised exits include industrials (Elysian II portfolio realisations, December 2025) and healthcare and industrials (United Living, 2023). Recent acquisitions include healthcare (IMS Euro, veterinary consumables, April 2025), business services (Activate Group, accident management, January 2024) and marketing services (Avant Group bolt-on for Gravity Global, July 2025; Gravity Global US bolt-ons, September 2025). The platform continues active deployment across the partner-aligned lower-mid-cap mandate. Detailed buyer names and multiple data available on Pro at €49/month.